- Open Access
Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors
© de Souza et al.; licensee BioMed Central Ltd. 2006
- Received: 12 April 2006
- Accepted: 10 August 2006
- Published: 10 August 2006
The tear film is a thin layer of fluid that covers the ocular surface and is involved in lubrication and protection of the eye. Little is known about the protein composition of tear fluid but its deregulation is associated with disease states, such as diabetic dry eyes. This makes this body fluid an interesting candidate for in-depth proteomic analysis.
In this study, we employ state-of-the-art mass spectrometric identification, using both a hybrid linear ion trap-Fourier transform (LTQ-FT) and a linear ion trap-Orbitrap (LTQ-Orbitrap) mass spectrometer, and high confidence identification by two consecutive stages of peptide fragmentation (MS/MS/MS or MS3), to characterize the protein content of the tear fluid. Low microliter amounts of tear fluid samples were either pre-fractionated with one-dimensional SDS-PAGE and digested in situ with trypsin, or digested in solution. Five times more proteins were detected after gel electrophoresis compared to in solution digestion (320 versus 63 proteins). Ontology classification revealed that 64 of the identified proteins are proteases or protease inhibitors. Of these, only 24 have previously been described as components of the tear fluid. We also identified 18 anti-oxidant enzymes, which protect the eye from harmful consequences of its exposure to oxygen. Only two proteins with this activity have been previously described in the literature.
Interplay between proteases and protease inhibitors, and between oxidative reactions, is an important feature of the ocular environment. Identification of a large set of proteins participating in these reactions may allow discovery of molecular markers of disease conditions of the eye.
- Additional Data File
- Mass Accuracy
- Mascot Score
- Lock Mass
- International Protein Index Database
The eye is covered by a thin, fluid film that serves several functions. It has critical roles in the optical system, lubricates the eye, provides nutrients and growth factors to the epithelium and serves as a barrier to the outside environment [1, 2]. In the last function, it protects the eye against infection. The tear film is an aqueous layer containing proteins and electrolytes secreted by the lacrimal gland situated within the orbit above the lateral end of the eye, and other accessory gland secretions. Additionally, tear fluid is in contact with the epithelium of the lid and, thereby, is in indirect contact with the blood circulation. Major tear proteins include lysozyme, lactoferrin, secretory immunoglobin A, serum albumin, lipocalin and lipophilin . The function of lysosyme, for example, is to lyse bacterial cell walls.
Tear fluid has become a body fluid of interest because it contains proteins in high concentration (about 8 μg/μl), it is relatively easy to collect, and several reports indicate that changes in its protein content can reflect normal or disease states. For example, electrophoretic and chromatographic analyses suggest that the tear protein patterns of diabetic patients are very different from those of healthy subjects [4, 5]. Biochemical characterization of tear proteins is also important for understanding tear deficiencies, contact lens incompatibilities, tear film instabilities and several other eye diseases.
Qualitative and quantitative techniques that have been applied to the study of the tear proteome include one- and two-dimensional electrophoresis [6, 7], enzyme-linked immunosorbent assay (ELISA) and high-performance liquid chromatography techniques . More recently, analytical methods that couple microliter sample size with high sensitivity and resolution have been used in detailed studies of changes in tear composition following injury or disease. These methods have been used to map tear protein profiles, and include several mass spectrometry technologies, such as matrix assisted laser desorption ionization-time of flight (MALDI-TOF), surface-enhanced laser desorption ionization-TOF (SELDI-TOF) and liquid chromatography coupled with electrospray ionization (LC/MS) [8–11].
However, despite these efforts to identify and catalogue the proteins present in the tear, only a very limited number of proteins have been described in the literature. Patterns obtained in two-dimensional gel electrophoresis suggest that tear fluid contains at least 200 proteins  and an LC/MS study of intact proteins indicated at least 17 different molecular weights . More recently, Li et al.  identified 54 different proteins using a combination of different proteomic approaches. Using a membrane-bound antibody array, Sack et al.  detected 80 different cytokines, chemokines and growth factors in tear samples. We were able to retrieve a total of about 60 described identifications and Harding  mentions a tear fluid proteome of about 80 proteins, including proteins only present in special conditions, such as allergy. The relatively low number of proteins identified, compared to other body fluids, may be due to the limited sensitivity of the methods employed , as well as the challenging composition of the tear fluid proteome, in which three proteins (lipocalin, lysozyme and lactoferrin) correspond to approximately 80% of the total protein concentration .
Recent developments in mass spectrometry-based proteomics (reviewed in Aebersold and Mann ) have dramatically increased our ability to analyze complex proteomes in-depth. In particular, a hybrid instrument, the linear ion trap-Fourier transform (LTQ-FT) mass spectrometer, combines very fast sequencing speed and high sensitivity with high resolution and mass accuracy . We have recently described very high confidence protein identification by a combination of extremely accurate peptide mass measurement with two stages of peptide fragmentation . These MS3 spectra are scored with a probability based algorithm, which significantly adds to the confidence of peptide identification and allows 'rescue' of proteins identified with only one peptide. In our laboratory, this instrument has allowed the unambiguous identification of low abundant proteins in signaling pathways and organelles [21, 22]. In addition, we also used the very recently developed LTQ-Orbitrap mass spectrometer  for analysis of tear fluid. In this instrument, ions are detected with high resolution by their motion in a spindle shaped electrode, instead of in a high magnetic field as is the case in the LTQ-FT spectrometer. We have recently shown that, by using a 'lock mass strategy', very high mass accuracy is routinely achievable in both the MS and MS/MS mode , which virtually eliminates the problem of false positive peptide identification in proteomics, and it is much easier than previously possible to identify post-translational modifications.
Here, we used both mass spectrometers in the analysis of the tear fluid proteome and report the unambiguous identification of 491 proteins. We observed a large number of proteases (32 proteins) and protease inhibitors (also 32 proteins), most not previously described as components of the tear fluid. In addition, we also identified 18 proteins that are involved in the anti-oxidant activity of the tear, of which 16 were not described previously. This in-depth analysis of the tear fluid should be of interest in ophthalmology and the results can be used as a reference to allow future characterization of disease states reflected in the tear fluid.
Comparison between in-gel and in-solution digestion
Comparison between LTQ-FT and LTQ-Orbitrap analysis
The complete list of proteins identified is summarized in Additional data file 1; this table lists the number of peptides observed for each identified protein, the Mascot score and the MS3 score for each peptide and protein (if available, that is, LTQ-FT data). Protein identification criteria were extremely stringent, requiring fully tryptic peptides with a mass error less than 3 ppm for the LTQ-FT or less than 5 ppm for the Orbitrap. For the FT data, the criteria needed were two matching peptides with a Mascot score of 27 or one matching peptide 'rescued' by an additional MS3 score, adding to a total probability score of at least 54. For the Orbitrap data, the criteria were two matching peptides with minimal score of 21. These criteria ensure an error rate in protein identification of less than 0.1%, so there should be no false positive protein identifications in our data set. In-gel analysis fully covered in-solution identifications. Therefore, all subsequent discussion is based on the in-gel data set.
Ontology of proteins identified
Hydrolases identified in tear fluid
Leukotriene A-4 hydrolase
Matrix metalloproteinase 8*
Matrix metalloproteinase 9*
Eosinophil cationic protein*
Adipocyte-derived leucine aminopeptidase†
Complement factor B†
Ubiquitin thiolesterase protein†
Palmitoyl-protein thioesterase 1
Acid phosphatase, prostate†
Chitinase 3-like protein 2†
Cytosolic nonspecific dipeptidase†
Protease inhibitors identified in the tear fluid
Inter-alpha-trypsin inhibitor heavy chain H1*
Inter-alpha-trypsin inhibitor heavy chain H2†
Inter-alpha-trypsin inhibitor heavy chain H4†
Similar to Lipocalin 1
Leukocyte elastase inhibitor*
Plasminogen activator inhibitor-2†
Placental thrombin inhibitor†
Pigment epithelium-derived factor*
Plasma protease C1 inhibitor†
Tissue inhibitor of metalloproteinase 1*
In addition, the classification of the identified proteins based on biological processes (Figure 6) revealed that at least 37 proteins belong to the immune system, 50 proteins are involved in immune response, such as antibodies and proteins from the complement system, 15 proteins are involved in inflammatory response, and 7 proteins are responsible for defense against pathogens. We also identified 31 proteins that are associated with response to wounding and blood coagulation. Finally, we identified 18 proteins that are involved in the metabolism of reactive oxygen species, such as peroxiredoxins and catalase, which may be functioning in the tear film in the defense against toxic oxygen compounds.
Over the past few decades, less then 80 proteins have been identified in tear fluid in normal or disease states . However, a more comprehensive identification of a larger number of proteins would be desirable to help identify molecular markers of a variety of diseases, such as dry eye syndrome, Sjogren syndrome, complications due to diabetes, conjunctivitis and others [28–30], as well as advance investigation of normal processes of wound healing and immune defense [14, 31]. In this study, using a mass spectrometry-based proteomic approach, we identified 491 proteins in tear fluid, using SDS-PAGE fractionation, in-gel trypsin digestion and independent analysis using two different high performance mass spectrometers. We analyzed material from a single, healthy donor as we wanted to characterize the normal tear fluid proteome. The basic composition and make up of such body fluid proteomes are likely to be very similar between healthy subjects, as we have already investigated in more detail in the case of the urinary and saliva proteomes. In these cases, we found that single and pooled samples were identical in terms of their main properties, such as molecular weight distributions and GO classification (Adachi et al.: The human urinary proteome contains more than 1,500 proteins, including a large proportion of membrane proteins, Genome Biology, in revision; de Souza, Schenk and Mann, unpublished data).
To determine the efficiency of different methods for the characterization of the tear fluid content, we compared an in-gel digestion of tear sample subjected to SDS-PAGE with an in-solution digestion of 1 or 4 μL of tear fluid, all analyzed using the LTQ-FT spectrometer. Our results showed that in-gel digestion identified about five times more proteins than in-solution digestion. This result was unexpected because in-solution digests of protein mixtures, in our experience, can readily identify several hundred proteins in a single analysis . This difference in the number of proteins identified by each method could partly be caused by the high 'dynamic range' of tear fluid, in which 80% to 90% of the protein content is represented by a minor group of proteins , which may make the identification of the lower abundant proteins difficult without pre-fractionation of the sample. Although we have no direct evidence, we also speculate that the inefficiency of the in-solution digestion could result from a lack of efficiency of the protocol itself, or from the high number of protease inhibitors and proteases present in the sample.
The ontology classification of the identified proteins revealed remarkable characteristics of the tear fluid, so far not described in the literature. Our data show that 200 proteins are primarily classified as intracellular molecules, while only 68 are classified as extracellular proteins. The presence of several intracellular metabolic proteins in tear fluid, such as lactate dehydrogenase, was initially described by van Haeringen and Glasius , who also demonstrated that these proteins originate from the cellular shedding of the epithelium that contacts the tear fluid. Most recently, several proteins that perform important functions in tear fluid, such as cathepsins and syaloglycoproteins, were also reported as proteins of epithelial origin [34, 35]. In some cases these intracellular proteins may have a functional role in tear fluid, and in other cases they may be present solely as the result of cellular necrosis, but could in principle still be relevant for diagnostic purposes.
We also show that 64 proteins (or approximately 12% of the total number of proteins described) belong to the functional group of hydrolase activity or protease inhibitors. It has been demonstrated that the levels of proteases and proteases inhibitors are in a constant equilibrium in tear fluid [35, 36] and that imbalance in these levels may lead to the development of disease states in the eye [31, 37]. Our large-scale proteomic investigation greatly extends the number of known proteases and protease inhibitors. These two groups of proteins were the best represented functional group in this study, indicating their importance in tear fluid. Proteins from these groups are associated with defensive mechanisms against pathogens, as well as extracellular matrix remodeling during healing and wounding processes [31, 38]. The biological process in which the largest group of proteins is involved is, not surprisingly, the immune defense of the eye. Of the 50 proteins classified as components of the immune defense (immune response, inflammatory response and defense response), 25 were functionally classified as hydrolases or protease inhibitors. The other proteins involved in the immune defense are, mainly, antibodies and proteins from the complement pathway.
We identified 18 proteins that were classified as molecules involved in the response to oxidative stress. It has been demonstrated that the tear fluid possesses anti-oxidative protection against reactive oxygen species (ROS) , and decrease in oxidative activity in tear fluid has been associated with several disease states, such as the development of diabetic dry eye disease . The only two proteins related to ROS elimination and already described as components of tear fluid are superoxide dismutase [41, 42] and oxyen-regulated protein 1 .
Our proteomic study highlights the importance of the balance of oxidative reactions, as well as the balance of hydrolase activity and protease inhibitors, as we report here 82 proteins involved in these processes (only 26 were described previously). These proteins may play crucial roles in maintaining the eye in a healthy condition. Perturbation of these proteins in the tear fluid may lead to the development of disease states, making them interesting targets for diagnostics and further functional characterization.
Tear sample collection
Samples of closed-eye tear were collected from one of us (GAS) using a 5 μl calibrated glass microcapillary tube (Blauband intraMARK, Brand GMBH, Werthein, Germany) without touching the eye globe or lids, in the course of one week and at different times of the day to avoid diurnal variation [34, 35]. One sample typically contained 2 μl. After collection, the tears were centrifuged at 14,000 g for 1 minute at 4°C (Eppendorf model 5417C, Eppendorf, Hamburg, Germany) to remove cellular debris, and stored at -20°C until analysis.
SDS-PAGE and in situdigestion
A tear sample (4 μL) was added to electrophoretic sample buffer (NuPAGE kit, Invitrogen, Karlsruht, Germany) and tear protein content was resolved by SDS-PAGE using a homogeneous 12% gel (NuPAGE gel, Invitrogen) under reducing conditions for 50 minutes with a constant voltage of 200 V. The gel was stained with Coomassie staining kit (NuPAGE, Invitrogen), as instructed by the manufacturer. After staining, two lanes of the gel were combined and then sliced in 13 pieces as indicated in Figure 1. The pieces were then subjected to in-gel reduction, alkylation and tryptic digestion. To reduce disulfide bonds, 100 mM DTT was added to a final concentration of 10 mM in the protein solutions and incubated for 1 h at 56°C in the dark. Free thiol (-SH) groups were subsequently alkylated with iodoacetamide (50 mM final concentration) for 45 minutes at room temperature. The reduced and alkylated protein mixtures were digested with sequence grade-modified trypsin (wt:wt 1:50; Promega, Madison, WI, USA) for 16 h at 37°C in 50 mM NH4HCO3, pH 8.0. Proteolysis was quenched by acidification of the reaction mixtures with 2% trifluoroacetic acid (Fluka, Buchs, Switzerland). Finally, the resulting peptide mixtures were desalted on RP-C18 STAGE tips as described  and diluted in 0.1% trifluoroacetic acid for nano-HPLC-MS analysis.
Samples of 1 and 4 μl of tear fluid were resuspended in 20 μl of 6 M urea and 2 M thiourea (Invitrogen) and submitted to reduction and alkylation as described above. For enzymatic digestion, Lys-C (wt:wt 1:50; Wako, Japan) was added to the solution for 16 h at room temperature, and the resulting peptides were desalted on RP-C18 STAGE tips. The same experiment was repeated using Lys-C for 16 h, followed by trypsin (1:50) for 24 h at room temperature.
All nano-HPLC-MS2 experiments were performed on an Agilent 1100 nanoflow system connected to a 7-Tesla Finnigan linear quadrupole ion trap-Fourier transform (LTQ-FT) mass spectrometer (ThermoElectron, Bremen, Germany), or connected to a LTQ-Orbitrap mass spectrometer (ThermoElectron), both equipped with a nanoelectrospray ion source (Proxeon Biosystems, Odense, Denmark).
Briefly, for in-gel samples, the mass spectrometer was operated in the data-dependent mode to automatically switch between MS, MS2, and MS3 acquisition. Survey full-scan MS spectra (m/z 300 to 1,500) were acquired in the Fourier transform ion cyclotron resonance (FT ICR) with resolution R = 25,000 at m/z 400 (after accumulation to a target value of 10,000,000 in the linear ion trap). The three most intense ions were sequentially isolated for accurate mass measurements by an ICR-FT SIM scan with 10 Da mass range, R = 50,000 and target accumulation value of 50,000. They were then fragmented in the linear ion trap by collisionally induced dissociation at a target value of 5,000. For MS3, up to three ions in each MS2 spectra (the most intense ions with m/z > 300) were further isolated and fragmented. Former target ions selected for MS2 were dynamically excluded for 30 s. Total cycle time was approximately 3 s. The general mass spectrometric conditions were: spray voltage, 2.4 kV; no sheath and auxiliary gas flow; ion transfer tube temperature, 100°C; collision gas pressure, 1.3 mTorr; and normalized collision energy, 30% for MS2 and 28% for MS3. Ion selection thresholds were: 500 counts for MS2 and 50 counts for MS3. An activation q-value of 0.25 and an activation time of 30 ms was applied in both MS2 and MS3 fragmentation . However, due to the expected higher complexity of in solution digestion samples, the acquisition method was adjusted to not perform SIM scan or MS3, but to sequence the five most intense peaks for obtaining MS2 data.
The mass spectrometer was operated in the data-dependent mode to automatically switch between Orbitrap-MS and Orbitrap-MS/MS (MS2) acquisition. Survey full scan MS spectra (from m/z 300 to 1,600) were acquired in the Orbitrap with resolution R = 60,000 at m/z 400 (after accumulation to a target value of 1,000,000 charges in the linear ion trap). The most intense ions (up to five, depending on signal intensity) were sequentially isolated for fragmentation in the linear ion trap using collisionally induced dissociation at a target value of 100,000 charges. The resulting fragment ions were recorded in the Orbitrap with resolution R = 15,000 at m/z 400.
For accurate mass measurements the lock mass option was enabled in both MS and MS/MS mode and the polydimethylcyclosiloxane (PCM) ions generated in the electrospray process from ambient air (protonated (Si(CH3)2O))6; m/z = 445.120025) were used for internal recalibration in real time. For single SIM scan injections of the lock mass into the C-trap the lock mass 'ion gain' was set at 10% of the target value of the full mass spectrum. When calibrating in MS/MS mode the ion at m/z 429.088735 (PCM with neutral methane loss) was used instead for recalibration .
Target ions already selected for MS/MS were dynamically excluded for 30 s. General mass spectrometric conditions were: electrospray voltage, 2.4 kV; no sheath and auxiliary gas flow; ion transfer tube temperature, 125°C; collision gas pressure, 1.3 mTorr; normalized collision energy, 32% for MS2. Ion selection threshold was 500 counts for MS2. An activation q-value of 0.25 and activation time of 30 ms was applied for MS2 acquisitions.
Stringent criteria were applied for protein identification, which was performed by searching the data against the International Protein Index database (IPI_human) by MASCOT (Matrix Science) and MSQuant (an in-house developed, open source software program). These criteria comprised: for LTQ-FT-ICR data, a mass accuracy within 3 ppm (in-gel digestion; average absolute peptide mass accuracy was 1.03 ppm) or 25 ppm (in-solution digestion; average absolute accuracy was 8.3 ppm); for LTQ-Orbitrap data, a mass accuracy of 5 ppm (average absolute accuracy of 1.01 ppm); at least two, fully tryptic, matching peptides per protein with a Mascot score for individual peptides (MS2) better than 27 (p ≤ 0.01), or one peptide with MS2 + MS3 score better that 54 (p ≤ 0.0001), when MS3 was performed. For in-solution digestion, proteins were considered identified if they had at least two peptides with score higher than 35. For Orbitrap data, the criteria were a mass accuracy within 3 ppm (average absolute peptide mass accuracy was 1.22 ppm) and at least 2 fully tryptic peptides per protein with a Mascot score better then 21 (p ≤ 0.01) for individual peptides (MS2). Differences in mass accuracy between in-solution samples (more complex compared to in-gel samples due to lack of pre-fractionation) was observed because the measurement of ion masses was not performed with the SIM method, leading to higher sequencing speed of the method at the cost of lower mass accuracy.
Experiments with a reversed database were performed as described in . The number of statistically significant peptides identified in the IPI database was 1,935, while the reverse database identified 12 peptides with statistical significance (0.6%) for the LTQ-FT data. However, these 12 peptides were not sufficient to identify a single protein (that is, none of the proteins had at least 2 peptides with score higher than 27 or one peptide with MS3 score higher than 54). The Orbitrap data included no peptides within statistical significance in the reverse database. Identified proteins were combined in a larger data set and initial GO characterization was done using the Protein Center tool (v0.62, Proxeon Biosystems).
Our data are freely available at the proteome database of the department of proteomics and signal transduction of the Max-Planck-Institut for Biochemistry .
The following additional data are available with the online version of this paper. Additional data file 1 lists all peptides and protein hits obtained in both LTQ-FT and LTQ-Orbitrap data.
- Dilly PN: Structure and function of the tear film. Adv Exp Med Biol. 1994, 350: 239-247.PubMedView ArticleGoogle Scholar
- Fleiszig SM, McNamara NA, Evans DJ: The tear film and defense against infection. Adv Exp Med Biol. 2002, 506: 523-530.PubMedGoogle Scholar
- Kijlstra A, Kuizenga A: Analysis and function of the human tear proteins. Adv Exp Med Biol. 1994, 350: 299-308.PubMedView ArticleGoogle Scholar
- Grus FH, Augustin AJ: High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients. Eur J Ophthalmol. 2001, 11: 19-24.PubMedGoogle Scholar
- Herber S, Grus FH, Sabuncuo P, Augustin AJ: Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis. Adv Exp Med Biol. 2002, 506: 623-626.PubMedGoogle Scholar
- Reitz C, Breipohl W, Augustin A, Bours J: Analysis of tear proteins by one- and two-dimensional thin-layer iosoelectric focusing, sodium dodecyl sulfate electrophoresis and lectin blotting. Detection of a new component: cystatin C. Graefes Arch Clin Exp Ophthalmol. 1998, 236: 894-899. 10.1007/s004170050177.PubMedView ArticleGoogle Scholar
- Molloy MP, Bolis S, Herbert BR, Ou K, Tyler MI, van Dyk DD, Willcox MD, Gooley AA, Williams KL, Morris CA, et al: Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic value. Electrophoresis. 1997, 18: 2811-2815. 10.1002/elps.1150181516.PubMedView ArticleGoogle Scholar
- Zhou L, Beuerman RW, Barathi A, Tan D: Analysis of rabbit tear proteins by high-pressure liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 2003, 17: 401-412. 10.1002/rcm.925.PubMedView ArticleGoogle Scholar
- Fung KY, Morris C, Sathe S, Sack R, Duncan MW: Characterization of the in vivo forms of lacrimal-specific proline-rich proteins in human tear fluid. Proteomics. 2004, 4: 3953-3959. 10.1002/pmic.200300849.PubMedView ArticleGoogle Scholar
- Zhou L, Huang LQ, Beuerman RW, Grigg ME, Li SF, Chew FT, Ang L, Stern ME, Tan D: Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res. 2004, 3: 410-416. 10.1021/pr034065n.PubMedView ArticleGoogle Scholar
- Grus FH, Podust VN, Bruns K, Lackner K, Fu S, Dalmasso EA, Wirthlin A, Pfeiffer N: SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci. 2005, 46: 863-876. 10.1167/iovs.04-0448.PubMedView ArticleGoogle Scholar
- Herber S, Grus FH, Sabuncuo P, Augustin AJ: Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis. 2001, 22: 1838-1844. 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7.PubMedView ArticleGoogle Scholar
- Li N, Wang N, Zheng J, Liu XM, Lever OW, Erickson PM, Li L: Characterization of human tear proteome using multiple proteomic analysis techniques. J Proteome Res. 2005, 4: 2052-2061. 10.1021/pr0501970.PubMedView ArticleGoogle Scholar
- Sack RA, Conradi L, Krumholz D, Beaton A, Sathe S, Morris C: Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci. 2005, 46: 1228-1238. 10.1167/iovs.04-0760.PubMedView ArticleGoogle Scholar
- Harding J: Biochemistry of the Eye. 1997, London: Chapman and HallGoogle Scholar
- Bucknall M, Fung KY, Duncan MW: Practical quantitative biomedical applications of MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom. 2002, 13: 1015-1027. 10.1016/S1044-0305(02)00426-9.PubMedView ArticleGoogle Scholar
- Azzarolo AM, Brew K, Kota S, Ponomareva O, Schwartz J, Zylberberg C: Presence of tear lipocalin and other major proteins in lacrimal fluid of rabbits. Comp Biochem Physiol B Biochem Mol Biol. 2004, 138: 111-117. 10.1016/j.cbpc.2004.02.012.PubMedView ArticleGoogle Scholar
- Aebersold R, Mann M: Mass spectrometry-based proteomics. Nature. 2003, 422: 198-207. 10.1038/nature01511.PubMedView ArticleGoogle Scholar
- Syka JE, Marto JA, Bai DL, Horning S, Senko MW, Schwartz JC, Ueberheide B, Garcia B, Busby S, Muratore T, et al: Novel linear quadrupole ion trap/FT mass spectrometer: performance characterization and use in the comparative analysis of histone H3 post-translational modifications. J Proteome Res. 2004, 3: 621-626. 10.1021/pr0499794.PubMedView ArticleGoogle Scholar
- Olsen JV, Mann M: Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proc Natl Acad Sci USA. 2004, 101: 13417-13422. 10.1073/pnas.0405549101.PubMedPubMed CentralView ArticleGoogle Scholar
- Schulze WX, Mann M: A novel proteomic screen for peptide-protein interactions. J Biol Chem. 2004, 279: 10756-10764. 10.1074/jbc.M309909200.PubMedView ArticleGoogle Scholar
- Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M: Proteomic characterization of the human centrosome by protein correlation profiling. Nature. 2003, 426: 570-574. 10.1038/nature02166.PubMedView ArticleGoogle Scholar
- Makarov A, Denisov E, Lange O, Horning S: Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer. J Am Soc Mass Spectrom. 2006, 17: 977-982. 10.1016/j.jasms.2006.03.006.PubMedView ArticleGoogle Scholar
- Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, Pesch R, Makarov A, Lange O, Horning S, Mann M: Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics. 2005, 4: 2010-2021. 10.1074/mcp.T500030-MCP200.PubMedView ArticleGoogle Scholar
- Hirosawa M, Hoshida M, Ishikawa M, Toya T: MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci. 1993, 9: 161-167.PubMedGoogle Scholar
- Steen H, Mann M: The ABC's (and XYZ's) of peptide sequencing. Nat Rev Mol Cell Biol. 2004, 5: 699-711. 10.1038/nrm1468.PubMedView ArticleGoogle Scholar
- Maere S, Heymans K, Kuiper M: BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics. 2005, 21: 3448-3449. 10.1093/bioinformatics/bti551.PubMedView ArticleGoogle Scholar
- Johnson ME, Murphy PJ: Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res. 2004, 23: 449-474. 10.1016/j.preteyeres.2004.04.003.PubMedView ArticleGoogle Scholar
- Kassan SS, Moutsopoulos HM: Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004, 164: 1275-1284. 10.1001/archinte.164.12.1275.PubMedView ArticleGoogle Scholar
- Leonardi A, Jose PJ, Zhan H, Calder VL: Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology. 2003, 110: 487-492. 10.1016/S0161-6420(02)01767-0.PubMedView ArticleGoogle Scholar
- Fini ME, Girard MT, Matsubara M: Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl. 1992, 202: 26-33.PubMedGoogle Scholar
- de Godoy LM, Olsen JV, de Souza GA, Li G, Mortensen P, Mann M: Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol. 2005, 7: R50-10.1186/gb-2006-7-6-r50.View ArticleGoogle Scholar
- van Haeringen NJ, Glasius E: Enzymes of energy-producing metabolism in human tear fluid. Exp Eye Res. 1974, 18: 407-409. 10.1016/0014-4835(74)90118-3.PubMedView ArticleGoogle Scholar
- Sack RA, Bogart BI, Beaton A, Sathe S, Lew G: Diurnal variations in tear glycoproteins: evidence for an epithelial origin for the major non-reducible > or = 450 kDa sialoglycoprotein(s). Curr Eye Res. 1997, 16: 577-588. 10.1076/ceyr.16.6.577.5069.PubMedView ArticleGoogle Scholar
- Sathe S, Sakata M, Beaton AR, Sack RA: Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Curr Eye Res. 1998, 17: 348-362. 10.1080/02713689808951215.PubMedView ArticleGoogle Scholar
- Barka T, Asbell PA, van der Noen H, Prasad A: Cystatins in human tear fluid. Curr Eye Res. 1991, 10: 25-34. 10.3109/02713689109007608.PubMedView ArticleGoogle Scholar
- Katunuma N, Shiota H, Le QT: Medical significance of cysteine protease inhibitors in mammalian secretory fluids. J Med Invest. 2003, 50: 154-161.PubMedGoogle Scholar
- Azar DT, Hahn TW, Jain S, Yeh YC, Stetler-Stevensen WG: Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy. Cornea. 1996, 15: 18-24. 10.1097/00003226-199601000-00005.PubMedView ArticleGoogle Scholar
- Rose RC, Richer SP, Bode AM: Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med. 1998, 217: 397-407.PubMedView ArticleGoogle Scholar
- Augustin AJ, Spitznas M, Kaviani N, Meller D, Koch FH, Grus F, Gobbels MJ: Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Arch Clin Exp Ophthalmol. 1995, 233: 694-698. 10.1007/BF00164671.PubMedView ArticleGoogle Scholar
- Crouch RK, Goletz P, Snyder A, Coles WH: Antioxidant enzymes in human tears. J Ocul Pharmacol. 1991, 7: 253-258.PubMedGoogle Scholar
- Behndig A, Svensson B, Marklund SL, Karlsson K: Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci. 1998, 39: 471-475.PubMedGoogle Scholar
- Rappsilber J, Ishihama Y, Mann M: Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem. 2003, 75: 663-670. 10.1021/ac026117i.PubMedView ArticleGoogle Scholar
- Olsen JV, Ong SE, Mann M: Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol Cell Proteomics. 2004, 3: 608-614. 10.1074/mcp.T400003-MCP200.PubMedView ArticleGoogle Scholar
- Tear Fluid Database. [http://proteome.biochem.mpg.de/tear/]
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.